Research
Hormonal
Accelerometer-derived measures of sleep duration and quality are heritable and genetically distinct from self-reported measures, with specific genetic variants (e.g., PDE11A, MEIS1) influencing sleep traits.
Use objective sleep tracking (accelerometers) to get a more accurate picture of your sleep genetics and quality, as self-reports may be biased. Focus on identifying specific sleep issues (duration, efficiency) rather than just feeling rested.
StrongSupportsHIGH confidence
We identify 47 genetic associations at P < 5 × 10−8, of which 20 reach a stricter threshold of P < 8 × 10−10. These include 26 novel associations with measures of sleep quality and 10 with nocturnal sleep duration.
Why this rating
Large-scale GWAS (N=85,670) with replication.
Source
Genetic studies of accelerometer-based sleep measures yield new insights into human sleep behaviour
Samuel E. Jones et al. · Nature Communications · 2019
DOI 10.1038/s41467-019-09576-1
cohort · n=85670Cited 328×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →